Overview - - The U.S. Food and Drug Administration (FDA) announced that it aims to increase the agency’s use of artificial intelligence (AI) ...

For More Information and To Stay Updated on The Latest Developments in The Artificial Intelligence MarketSize, Download FREE Sample Pages: ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...

The global AI In Healthcare Market size is projected to be valued at USD 26.6 Billion in 2024 and reach USD 187.7 billion by 2030, growing at ...

The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

Lantern Pharma's Q1 2025 earnings reveal clinical progress, AI commercialization plans, and financial discipline.

Stuart J. Schnitt, MD, discussed how AI enhances cancer diagnoses and the need for professional oversight, ethical clarity, and equitable adoption.

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...